Drw Securities, LLC Aldeyra Therapeutics, Inc. Transaction History

Drw Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$7.26 - $13.29 $295,344 - $540,650	-40,681 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $161,030 - $339,822	23,681 Added 139.3%	40,681 $561,000
Q2 2018 Aug 14, 2018	BUY	$6.95 - $9.18 $34,750 - $45,900	5,000 Added 41.67%	17,000 $135,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $46,800 - $129,600	12,000	12,000 $86,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.